GrandOmics Biosciences

GrandOmics focuses on the application of long-read sequencing technology;we developed sequencing solutions for different biology research fields by integrating the advantages of multiple sequencing platforms, including NGS and Long-read Sequencing. GrandOmics also actively engaged in the independent development of bioinformatics software and explore the application of long-read sequencing technology in clinical medicine. In response to the data processing problems of the long read sequencing technology in the application fields of animal and plant genome research, pathogenic microorganism detection, and clinical testing, we have developed NextDenovo, NextPolish, GrandBox, GrandPathogen and other bio-information algorithms and platforms to analysis genomic data. Contact us...

Grandomics biosciences operates in the Biotechnology industry.

Grandomics biosciences's revenue is 11m - 100m

Grandomics biosciences has 11 - 50 employees.